| Literature DB >> 31174920 |
Alaide Chieffo1, Francesco Burzotta2, Federico Pappalardo3, Carlo Briguori4, Roberto Garbo5, Giulia Masiero6, Elisa Nicolini7, Flavio Ribichini8, Carlo Trani2, Belén Cid Álvarez9, Oriol Rodríguez Leor10, Raúl Moreno11, Ricardo Santos12, António Fiarresga13, João Brum Silveira14, Armando Pérez de Prado15, Giuseppe Musumeci6, Giovanni Esposito16, Giuseppe Tarantini17.
Abstract
Percutaneous coronary intervention (PCI) is establishing as the last remaining revascularization option in an increasing number of patients affected by complex coronary artery disease not suitable for surgery. Over the past decade, percutaneous left ventricular assist device (pLVAD) has increasingly replaced intra-aortic balloon pump to provide hemodynamic support during such non-emergent complex high-risk indicated procedures (CHIP) averting the risk of circulatory collapse and of adverse events in long lasting and/or complicated procedures. This review article aims to report the key factors to define CHIP, to summarize the available pLVAD which have CE mark for temporary mechanical LV support and to discuss the rationale of their use in this subset of patients. Based on the expertise of the Italian Society of Interventional Cardiology working group, with the endorsement from Spanish and Portuguese Society of Interventional Cardiology working groups, it will provide several practical suggestions in regards to the use of pLVAD in different clinical CHIP scenarios.Entities:
Mesh:
Year: 2019 PMID: 31174920 DOI: 10.1016/j.ijcard.2019.05.065
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164